Canopus Biopharma Inc. announced a fully executed amendment to its original distributor partnership beverage agreement with the world-renowned beverage company, PepsiCo, Inc. The original agreement (announced to markets on September 7, 2023) established PepsiCo as the exclusive cold-beverage provider for BHC's unattended retail platforms across the company's North American footprint. Under this agreement, PepsiCo to date has provided BHC with over $250,000 in deployed unattended retail equipment, customized vendor pricing and national equipment repair support. By way of amendment, BHC has further advanced its strategic partnership with PepsiCo as the company is now in receipt of approval for PepsiCo's Direct to Store Delivery program.

The program allows BHC to transition away from purchasing wholesale products from licensed distributors and instead to purchase exclusively and directly from PepsiCo securing significantly better pricing and rebate incentives. These unique pricing structures will allow BHC to significantly increase its margins, as well benefit from further reduction in cost through the benefits of a revised and custom-tailored rebate program-built around BHC's best selling Pepsi SKUs.